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ABSTRACT The structure of the rat ciliary neurotrophic factor (CNTF) gene and the 
regulation ofCNTF mRNA levels in cultured glial cells were investigated. The rat mRNA 
is encoded by a simple two-exon transcription unit. Sequence analysis of the region 
upstream of the transcription start-site did not reveal a typical TATA-box consensus 
sequence. Low levels of CNTF mRNA were detected in cultured Schwann cells, and 
CNTF mRNA was not increased by a variety of treatments. Three-week-old astrocyte-
enriched cell cultures from new-born rat brain contained easily detectable CNTF mRNA. 
In astrocyte-enriched cultures, upregulation of CNTF mRNA levels was observed after 
treatment with IFN-"{. CNTF mRNA levels were down-regulated in these cells by treat-
ments that elevate intracellular cyclic AMP and by members of the fibroblast growth 
factor (FGF) family. The implications of these results for potential in vivo functions of 
CNTF are discussed. © 1993 Wiley-Liss, Inc. 
INTRODUCTION 
Ciliary neurotrophic factor (CNTF) is a 22 kDa acidic 
cytosolic protein that was originally identified and par-
tially purified as target-derived neurotrophic factor for 
chick ciliary parasympathetic neurons; hence its name 
(Barbin et aI., 1984; Manthorpe et aI., 1986). In the 
course of further investigations performed with CNTF 
purified to homogeneity and also recombinant CNTF, it 
became apparent that the spectrum of biological actions 
of CNTF is much broader. CNTF proved to be a power-
ful neurotrophic molecule not only for chick E8 para-
sympathetic cholinergic neurons but also for Ell sym-
pathetic and EI0 sensory neurons (Barbin et aI., 1984), 
chick E6 spinal motoneurons (Arakawa et aI., 1990), 
chick E8 nodose ganglion neurons, and EI0 trigeminal 
neurons (Sendtner et aI., 1991). Moreover, it was shown 
that CNTF induces cholinergic properties in rat sympa-
thetic neurons in culture as reflected by an increase in 
choline acetyltransferase and a reduction of tyrosine 
hydroxylase (Saadat et aI., 1989) as well as inducing 
differentiation and VIP expression by chick sympathetic 
neuronal precursors (Ernsberger et aI., 1989). CNTF 
© 1993 Wiley-Liss. Inc. 
has also been shown to induce differentiation of rat 
optic nerve 0-2A progenitor cells to type-2 astrocytes 
(Lillien et aI., 1988), induce acute-phase protein expres-
sion in hepatocytes (Schooltink et aI., 1993), activate 
transcription of neuropeptide genes in neuroblastoma 
cells (Symes et aI., 1993), and promote survival and 
maturation of cultured oligodendrocytes (Bergsteindot-
tir et aI., 1993). 
The very broad spectrum of biological actions pre-
dominantly demonstrated in vitro but also in vivo (Op-
Received December 22,1992; accepted March 29. 1993. 
Abbreviations: Act D, actinomycin D; 8-br-cAMP. 8-bromo-adenosine-cAMP; 
dibu-cAMP, dibutyryl-adenosine-cAMP; CGRP, calcitonin gene related peptide; 
CNTF, ciliary neurotrophic factor; CHX, cycloheximide; Dex, dexamethasone; 
EGF, epidermal growth factor; FGF, fibroblast growth factor; FK, forskolin; IFN, 
interferon; IFG-I, insulin-like growth factor I; IL-lj3, Interkeukin-lj3; IL-6, inter-
leukin-6; KA, kainic acid; PDGF-AB, platelet derived growth factor AB; RA, all 
trans retinoic acid; SC CM, Schwann cell conditioned medium; SC co-cult, Schwann 
cell co-culture; Sub P, substance P; T3, 3,3' ,5-triiodo-L-thyronine; TGF-j31' plate-
let transforming growth factor j3I; TPA, phorbol 12-myristate 13-acetate; VIP, 
vasoactive intestinal peptide. 
Address reprint requests to Patrick Carroll, Max-Planck Institute for Psychia-
try, Department of Neurochemistry, Am Klopferspitz 18a, 8033 Planegg, Ger-
many. 
CILIARY NEUROTROPHIC FACTOR REGULATION IN GLIAL CELLS 177 
penheim et aI., 1991; Sendtner et aI., 1990, 1992b), 
after local or systemic administration, is in distinct con-
trast to the very restricted expression of CNTF exclu-
sively to the postnatal period and confined to myelinat-
ing Schwann cells and a subpopulation of type-1 
astrocytes (Stockli et aI., 1991). Besides evaluation of 
the physiological function of CNTF by gene targeting 
and its potential patho-physiological function as a le-
sion factor, the elucidation of the regulation of its syn-
thesis and the restricted cellular expression represent a 
most important step on the way to a comprehensive 
understanding of the physiological roles ofCNTF. With 
this in mind, we analysed the genomic organisation of 
the CNTF gene, characterised its promoter region and 
investigated the regulation of CNTF synthesis in cul-
tured Schwann cells and astrocytes under a great vari-
ety of experimental conditions. 
MATERIALS AND METHODS 
Materials 
Actinomycin D, forskolin (7f3-acetoxy-8,13-epoxy-1 
a,6f3,9a-trihydroxylabd-14-ene-11-one),1,9-dideoxy-for-
skolin, cytosine-f3-D-arabinofuranoside (ara-C), norepi-
nephrine, isoproterenol, 8-bromo-adenosine-cAMP (8-
br-cAMP), dibutyryl-adenosine-cAMP (db-cAMP), mouse 
epidermal growth factor (EGF), ionomycin, 3,3 '-5-tri-
iodo-L-thyronine (T3), all trans retinoic acid (RA), calci-
tonin gene related peptide (CGRP), glucagon, methio-
nine enkephalin (Met-enk), phorbol 12-myristate 13-
acetate (TPA), cycloheximide (CHX), kainic acid (KA), 
dexamethasone (Dex), histamine, and testosterone were 
purchased from Sigma Chemical Co. (St. Louis). Rat 
recombinant basic FGF (bFGF), human recombinant 
IL-6, human plasma thrombin, okadaic acid, and sub-
stance P were purchased from Boehringer Mannheim. 
Porcine platelet transforming growth factor 131 (TGF-
(31) was purchased from R&D Systems, Inc. Human 
platelet derived growth factor AB (PDGF -AB) was from 
British Biotechnology (Oxford). Rat recombinant inter-
ferons a and 13 were purchased from Bioferon Gmbh. 
Interleukin-1f3 (IL-1f3) was a gift from Dr. A. Gronen-
born (Martinsried) by courtesy of Biogen (Geneva). Hu-
man recombinant insulin-like growth factor I (lGF-1) 
was generously provided by Dr. A. Skottner (Kabi Pep-
tide Hormone, Stockholm). Fibroblast growth factor 5 
(FGF-5) and kFGF (also called FGF-4) were gifts from 
Mitchell Goldfarb and Claudio Basilio, respectively (Co-
lumbia University, NY). Cell·culture media and trypsin-
EDTA were from GibcolBRL. 
Isolation of Genomic Clones 
Genomic Southern blots of rat DNA were hybridised 
against a variety of degenerate oligonucleotides whose 
sequence was based on peptide sequences of purified 
rat CNTF (M. Sendtner and F. Lottspeich, Martinsried). 
One oligonucleotide 33-mer, LP3 (5 ' -CTCCTCIAGCT-
GRTAIGCAAAKGRCTIACCTG-3 ' , based on the CNTF 
peptide sequence QVSAFAYQLEEL) detected a single 
band of 5 kb in an EcoRI digest which was also visible 
amongst the multiple bands detected by several other 
oligonucleotides based on different protein sequences. 
LP3 was used to screen a rat genomic bank of partial 
EcoRI-digested DNA in A vector Charon 4A (Clontech). 
Hybridising clones were isolated and confirmed as CNTF 
by sequencing and by hybridisation against CNTF cDNA, 
which has been isolated in parallel by PCR methodol-
ogy (Sttickli et aI., 1989). Sequencing was performed by 
the Sanger dideoxy method on plasmid template. 
Brain Astroglial Cell Culture 
New-born Wistar rats were sacrificed and brains were 
dissected out. Mter removal of the meninges the tissue 
was cut into small pieces and treated with trypsin. Cells 
were mechanically dissociated and plated out in Costar 
162 cm2 culture flasks in 10% fetal calf serum (FCS) in 
DMEM. When the cells had almost reached confluence 
cytosine arabinoside (Ara-C, 20 fLM) was added to the 
medium for 3 days to suppress fibroblast proliferation. 
Cells were grown for 2-3 weeks in Costar 162 cm2 flasks, 
detached by trypsinisation and 3 x 105 cells were plated 
out on 6 cm dishes. Mter a further 3 to 7 days in culture 
the cells were treated for the indicated times (see Re-
sults) and used for RNA analysis. 
Sciatic Nerve Schwann Cell Culture 
Schwann cell cultures were prepared as described by 
Matsuoka et al. (1991). Briefly, sciatic nerves from new-
born rats were treated with collagenase and then trypsin. 
Mter trituration the cells were plated out onto 6 cm 
dishes in DMEMl1O% FCS. Mter two cycles of Ara-C 
treatment the cells were replated on poly-lysine coated 
dishes in DMEMl10% FCS and 10 fLM forskolin to pro-
mote Schwann cell proliferation. Expanded Schwann 
cell cultures were kept for 1-3 weeks without forskolin 
before being used for experiments. 
Primer Extension Assay 
Poly A + RNA was prepared from 4-week-old cultures 
of rat brain astrocytes using the Quick-Prep mRNA 
purification kit (Pharmacia) following the manufac-
turers' instructions. The priming oligonucleotide was 
a 30-base antisense oligonucleotide (PEXT-l) from 
the 5' -end of the CNTF protein coding region: 5' -GAA-
GGGTCAGAGGTGTITGCTCTGCGAAAG-3' (bases 82-
111 in the cDNA, Stockli et aI., 1989). PEXT-1 was 5' 
end-labelled with 32P_ATP and polynucleotide kinase. 
Hybridisation of primer and RNA was as described in 
Ausubel et al. (1990). The reverse transcription reac-
tion was carried out in the following conditions: 10 fLg 
poly A + RNA, 50 mM Tris (pH 8.3), 40 mM KCI, 7 mM 
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MgC12, 1 mM DTT, 50 fJ-g/ml BSA, 1 mM dNTPs, and 20 
U AMV reverse transcriptase (Life Sciences). Mter 30 
min at 42°C, fresh enzyme was added and the reaction 
was continued at 50°C for 30 min. As a positive control a 
synthetic sense RNA transcript that extended from the 
Apa I site at -120 relative to the 5' -end of the longest 
cDNA clone (Stockli et aI., 1989) through the first exon, 
thus containing the binding site for the primer exten-
sion oligonucleotide, was made by in vitro transcription 
from the plasmid p64, a 4.5 kb ApaI/SalI fragment of 
the rat CNTF gene in the Bluescript vector. The primer 
extension product generated from this template would 
be ~200 bases. The samples were separated on a 6% 
sequencing gel alongside the products of a sequencing 
reaction generated from PEXT -1 with a rat CNTF ge-
nomic clone as template. 
5' RACE (Rapid Amplification of cDNA Ends) 
The protocol described by Frohmann (1990) was fol-
lowed. Reverse transcription was initiated from various 
antisense primers whose sequences were based on the 
5' sequences of rat CNTF cDNA using polyA + RNA 
from rat astrocyte cultures as template. The sequences 
of the oligonucleotides were as follows: Pal-2 (20-mer) 
5'-TCAGTGCTTGCCACTGGTAC-3'; PEXT-1 (30-mer) 
5' -GAAGGGTCAGAGGTGTTTGCTCTGCGAAAG-3', 
PEXT-2(30-mer)5'-GGAAATAAGTGAGCTGGTTTGCT-
TCTGTGT-3'. The resulting cDNA was tailed with gua-
nosine residues and after removal of priming oligos by 
Centricon-30 filtration, PCR was carried out using 
oligo-dC primer and primers upstream from the origi-
nal reverse transcriptase priming oligonucleotides-
"nested PCR." PCR products were either cloned into 
pUC19 vector and sequenced using the Sanger dideoxy 
method or sequenced directly using the Applied Biosys-
terns automated sequencing machine. 
RNA Isolation and Northern Blot Analysis 
Cells (about 1 million) were treated as described in 
the Results section and RNA was isolated by the method 
ofChomczynski and Sacchi (1987). Briefly, after remov-
ing the medium and adding 0.5 ml solution D (4 M 
guanadinium isothiocyanate; 25 mM sodium citrate, pH 
7.0; 0.5% Sarkosyl and freshly added 0.1 M 2-mercap-
toethanol) and a known amount (usually 10 pg) of re-
covery standard (a 600 bp synthetic sense CNTF RNA 
transcript), the mixture was collected by scraping into a 
microfuge tube containing 500 fJ-l phenol, 100 fJ-l 
chloroformlisoamyl alcohol (5011), and 50 fJ-12M sodium 
acetate (pH 4.1). The sample was vortexed, left on ice 10 
min, centrifuged for 10 min, and the supernatant was 
re-extracted with 0.5 ml chloroformlisoamyl alcohol. RNA 
was precipitated by the addition of 0.5 ml isopropanol 
at -20°C for 1-2 h. After centrifugation the pellet was 
resuspended in solution D and again precipitated with 
isopropanol. Generally, about 20 fJ-g total RNA was re-
covered from a confluent 6 cm plate. 
RNA samples were separated on 1.5% agarose gels 
containing formaldehyde (Sambrook et aI., 1989). Gels 
were vacuum-blotted onto Hybond-N membrane (Am-
ersham). 
Pre-hybridisation and hybridisation were carried out 
in 10% formamide; 5x SSC; 20 mM sodium phosphate, 
pH 7.0; 5x Denhardt's solution; 50 mM EDTA; 1 % SDS, 
and 500 fJ-g/ml denatured herring sperm DNA. The hy-
bridisation temperature was 65°C. A 32P-labelled probe 
(l09 dpm/fJ-g) was prepared by in vitro transcription ofa 
CNTF protein-coding region template in appropriately 
linearized Bluescript plasmid. Blots were washed twice 
in 2 x SSC/O.1 % SDS at RT, once in the same buffer at 
60°C for 30 min and once at 70°C in 0.1 x SSC/0.5% SDS 
for 1 h. 
The autoradiograph of the Northern blot showing in-
creased CNTF mRNA expression in astrocyte-enriched 
cultures after IFN-)' treatment was scanned using an 
LKB laser densitometer. 
RESULTS 
Structure of the Rat CNTF Gene 
The sequence of the rat CNTF gene and flanking 
regions is shown in Figure 1A,B. By comparison with 
the cDNA sequence (Stockli et aI., 1989), the CNTF 
gene is shown to be composed oftwo exons separated by 
an intron of 1 kb. A transcriptional start-site was iden-
tified by primer extension of a CNTF -specific oligonu-
cleotide against cultured rat astrocyte poly A + RNA 
(Fig. 2A, lane 1). Primer extension using positive con-
trol sense RNA transcript generated the expected 200 
base product (Fig. 2A, lane 2). The transcriptional start-
site shown here corresponds with that suggested by 
cDNA cloning (Stockli et aI., 1989). 
The existence of a longer ~4 kb RNA species that 
hybridised to a labelled CNTF RNA probe, in addition 
to the more abundant 1.2 kb mRNA (Rudge et aI., 1992 
and our unpublished observation), as well as the obser-
vation that in rabbit sciatic nerve CNTF mRNA is ~4 
kb (Lin et aI., 1989), led us to investigate in detail whether 
there are extensions of the rat CNTF mRNA at the 
5' -end. 5' RACE experiments were carried out using 
three anti sense oligonucleotide specific for the 5' -end of 
the rat astrocyte CNTF mRNA (Fig. 2B). For all combi-
nations of oligonucleotides, the size of the major PCR 
product corresponded to the transcriptional start pre-
dicted by both cDNA cloning and primer extension. All 
attempts to amplify higher molecular weight species 
that appeared in low amounts in some PCR reactions 
were unsuccessful. The PCR products of the 5' RACE 
protocol were cloned and sequenced, the results of which 
further corroborated the previous findings (data not 
shown). Thus the 5' -untranslated region of rat CNTF 
mRNA is 75 bases long. 
The promoter region does not contain a typical TATA 
box sequence. The sequence TAQAAAA at position -31, 
may serve this function. A transcriptional start-site for 
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Fig. 1. A: Structure of the rat CNTF gene. Boxes represent the 2 exons and shaded areas show the 
CNTF protein-coding region. B: The sequence of the rat CNTF gene and derived CNTF protein sequence, 
partial intron, and 5' and 3' flanking sequences. Underlined sequences represent a potential AP-I 
binding site, G-rich sequences, potential TATA-box sequence in the 5'-flanking region, and the polyade-
nylation signal AATAAA at the end of the gene. 
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the human CNTF gene has been suggested (Lam et al., 
1991) which differs from that shown here for the rat 
gene. The human and rat gene sequences are compared 
in Figure 2C. The human mRNA would have a 5' un-
translated region of only four bases. A consensus AP-l 
sequence, which mediates the transcriptional regula-
tion functions of the fosljun family of DNA binding pro-
teins (for review, see Herschman, 1991), is found at -72 
and is conserved in the human gene (Lam et al., 1991). 
A well-conserved G-rich sequence, found between -61 
and - 45, has the characteristics of a GT -box, which is a 
potential target sequence for the DNA binding protein 
SP-l and the related GT box-binding proteins (Hagen 
et al., 1992; Kingsley and Winoto, 1992). 
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Fig. 2. A: Primer extension analysis of cultured rat brain poly A' 
RNA using a 32P·labelled base CNTF antisense synthetic oligonucle· 
otide (PEXT·l) encompassing bases 82 to 111 of the CNTF cDNA. G 
and T: sequencing reaction from PEXT·l against a plasmid clone con· 
taining the rat CNTF promoter and first exon. Lane 1: primer exten· 
sion using rat astrocyte poly A + as template. Lane 2: primer extension 
using an in vitro·synthesized positive control template RNA extending 
from position -120 relative to the proposed transcriptional start·site. 
Arrows indicate the primer extension products. Negative controls were 
(not shown) tRNA, adult rat liver total RNA, and a 30.base 32p. 
labelled sense CNTF oligonucleotide as priming oligonucleotide. In all 
cases no extension products were observed. B: Diagram showing the 
position of oligonucleotides used for primer extension analysis and 5 ' 
RACE protocol. Base numbering is derived from the rat cDNA se· 
quence (Sttickli et al., 1989): Pal·2 (bases 243-261); PEXT·l (bases 
82·111); PEXT·2 (bases 28-57). C: Comparison of the sequences at the 
5' ·ends of the rat and human CNTF genes. Conserved AP·l, G·rich, 
and TATA box in the rat gene are indicated. The TATA box for the 
human gene proposed by Lam et al. (1991) is underlined by a broken 
line. 
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The sequences of the intron donor and acceptor sites 
correspond well to the consensus sequences suggested 
by Padgett et al. (1986). 
Consensus donor: CAG.!.GT(AlG)AGT 
CNTF donor: TAT.L. GTAAGT 
Consensus acceptor: YYYYYYXCAG,l.G 
CNTF acceptor: CCTTGGCTAG.J, G 
CNTF mRNA Expression in Cell Culture 
A number of different cell types were tested by North-
ern blot analysis for CNTF mRNA expression including 
3-4-week-old astrocyte-enriched cultures from newborn 
rat brain, primary Schwann cells, microglia-enriched 
cultures from new-born rat brain, C6 glioma, RN22 
Schwannoma, NIH 3T3 fibroblasts, and primary fibro-
blasts from newborn rat sciatic nerve. Only primary 
astrocytes, Schwann cells and C6 glioma cells showed 
detectable levels of the 1.2 kb CNTF mRNA, astrocyte 
cultures expressing by far the highest levels of mRNA 
(Fig. 3A, data for all cell types not shown). 
A wide range of treatments and factors were tested 
for their ability to alter CNTF mRNA levels in primary 
rat astrocytes (Table 1). Forskolin, cAMP analogues, 
isoproterenol, and norepinephrine reduced CNTF mRNA 
levels (Fig. 3A,D, data for norepinephrine not shown). 
The CNTF mRNA levels in astrocyte cultures were also 
down-regulated by four members ofthe fibroblast growth 
factor family. bFGF, aFGF (data not shown), k-FGF, 
and FGF-5 (Fig. 3B). Heparin was used to potentiate 
the activity of FGF-5 and k-FGF (Hughes et aI., 1993; 
Delli-Bovi et aI., 1988). Only treatment of astrocytes 
with ,,(-interferon resulted in a modest (3-fold, as mea-
sured by densitometry scanning) increase in CNTF 
mRNA levels (Fig. 3C). 
The level of CNTF mRNA was very low in Schwann 
cells and no treatment was found which raised it above 
the basal levels. It may be possible that Schwann cells 
in culture down-regulate their own CNTF mRNA syn-
thesis by production of diffusible or non-diffusible fac-
tor(s). To test whether such factor(s) could down-regu-
late CNTF mRNA levels in astrocytes, astrocytes were 
co-cultured with Schwann cells or in medium condi-
tioned by Schwann cells. Neither of these treatments 
altered the levels of CNTF mRNA in astrocytes or 
Schwann cells (see Table 1). 
Expression of CNTF mRNA in Astrocytes Derived 
From Different Brain Regions 
Heterogeneity between cultured astrocytes derived 
from different brain regions in their GF AP content, glu-
tamate uptake, responses to j3-adrenergic stimulation 
(for review see Wilkin et aI., 1990), and response to 
bFGF (Perraud et al., 1990) has been reported. In order 
to ascertain whether there are differences in CNTF 
mRNA expression in different astrocyte populations, 
we plated cells from cortex, hippocampus, and cerebel-
lum and investigated CNTF mRNA expression and for-
skolin responsiveness by Northern blot analysis. CNTF 
mRNA was found in astrocytes of all of these brain 
regions (Fig. 4). Immunohistochemical analyses of these 
cultures using antibodies for GFAP and Thy 1 to deter-
mine the relative proportions of astrocyte and fibro-
blasts revealed differences from experiment to experi-
ment, so that the differences in CNTF mRNA amounts 
between cortical, cerebellar, and hippocampal cultures 
shown in Figure 4 are not suggested to represent re-
gional variation in CNTF expression. In all cases, CNTF 
mRNA levels were down-regulated by forskolin treat-
ment (Fig. 4). 
CNTF mRNA Half-Life Estimation 
Astrocyte cultures were treated with either actino-
mycin D alone or forskolin and actinomycin D together. 
Densiometric scanning of the autoradiograph shown in 
Figure 5 showed that in the presence of the transcrip-
tional inhibitor actinomycin D, CNTF mRNA levels had 
decreased to 50% by 6 h. Thus the half-life ofthe CNTF 
mRNA is 6 h. In the presence offorskolin, the decrease 
in CNTF mRNA levels was delayed, suggesting possible 
post-transcriptional effects offorskolin on CNTF mRNA. 
DISCUSSION 
The structure of the rat CNTF gene has been eluci-
dated and the regulation of the CNTF mRNA was in-
vestigated in a number of cell types. The gene is split 
into two exons of 190 and 1,003 bp separated by an 
intron of about 1 kb. By primer extension and 51 -RACE 
methodology we show that rat CNTF mRNA has a 5'-
untranslated region of 75 bases, of average length for 
eucaryotic genes (Kozak, 1987). If the ~4 kb RNA spe-
cies that hybridises to a CNTF RNA probe in Northern 
blot analysis (Rudge et aI., 1992) is generated from the 
CNTF gene it most probably is derived from alternative 
polyadenylation site usage. 
The rat CNTF promoter region does not contain a 
typical TATA box, although the related sequence 
TAGAAAA is found at the appropriate position ( ~ -30)rel-
ati~ to the transcriptional start-site, and this sequence 
may function as a site for transcription complex forma-
tion. A different transcriptional start-site has been pro-
posed for the human CNTF (Lam et aI., 1991), generat-
ing a 5' untranslated region of only four bases. The 
shortest 5 /-noncoding sequence as deduced from a sur-
vey of 699 vertebrate sequences is seven bases (Kozak, 
1987). In three other cases where the noncoding se-
quence was less than ten bases multiple translation 
initiation sites were observed. The TATA box suggested 
for the human gene is not conserved in the rat. The rat, 
mouse, and human genes all contain the sequence TAGA 
at the -30 position relative to the transcription start-
site suggested in this paper. Considering the above ob-
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Fig. 3. A. Northern blot showing expression of CNTF mRNA in 
3-week-old astrocyte-enriched cultures from newborn rat brain and in 
cultured rat Schwann cells. Recovery standard (rec. st.) was a 600 base 
sense CNTF in vitro transcript (10 pg/lane). NT, Untreated cells; FK, 
forskolin (10 ILM); ddFK, dideoxy-forskolin (10 ILM); lP, Isoproterenol 
(6.25 ILM); bFGF, basic FGF (20 nglml medium). All treatments 24 h. 
B: Northern blot analysis of CNTF mRNA levels in 3-week-old astro-
cyte-enriched cultures from new-born rat brain. NT, untreated cells; 
FK, forskolin (10 ILM); bFGF, human basic FGF (20 nglmll ; recombi-
servations, the CNTF promoter may be included in the 
class of promoters that have atypical TATA boxes and 
are not highly GC-rich (Smale and Baltimore, 1989). In 
mutagenesis experiments, point mutations of the third 
position T of the TATA sequence to either G or A caused 
a reduction in transcriptional activity (Giangrande et al., 
1989; Myers et al., 1986). Pugh and Tjian (1991) sug-
+ bep + bep 
• 
CNTF mRNA 
rec. st. 
NT L-.J 
8-bromo 
0 cAMP 
nant human FGF-5 (100 nglmll + heparin. Human kFGF (100 ngl 
mll + heparin. Heparin (500 ILglmll. Treatment for 24 h. C: Northern 
blot analysis of CNTF mRNA levels in 3-week-old astrocyte-enriched 
cultures from new-born rat brain. NT, untreated cells; IFN--y, inter-
feron--y (300 Ulmll . Treatment for 24 h. D: Northern blot analysis of 
CNTF mRNA levels in 3-week-old astrocyte-enriched cultures from 
new-born rat brain. NT. untreated cells. 8-bromo cAMP (1 mM). Treat-
ment for 24 h. 
gest that for promoters lacking a typical TATA box bind-
ing of the SP-1 protein at GC-rich sequences near the 
transcriptional start site may function to tether the 
transcription complex upstream of the initiation site. 
Clarification of the exact mechanism of transcriptional 
initiation for CNTF requires further study. So far, we 
have failed to demonstrate promoter activity by trans-
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TABLEl. Treatments used to investigate factors which alter CNTF mRNA 
levels in astroglial and Schwann cell cultures 
Treatment Concentration 
)'-IFN 300 U/ml 
forskolin 1-20 fLM 
dd-FK 20fLM 
8-br-cAMP 1mM 
dibu-cAMP 1mM 
bFGF 2-20ng/ml 
kFGF 100 ng/ml 
FGF-5 100 ng/ml 
aFGF 20ng/ml 
Isoproterenol lOfLM 
Norepinephrine 0.1-0.2 mM 
O.l%FCS 
SCCM 
SC co-cult. 
Low density 
Cycloheximide 10 fLg/ml 
Ionomycin 1 fLg/ml 
Kainicacid 50fLM 
IL-1 10 Ulml 
IL-1 + CHX 
IL-1 + Dex 
IL-1 + RA 
IL-6 100U/ml 
T3 1fLM 
Dexamethasone 1fLM 
T3 + RA 
Retinoic acid 1fLM 
EGF 20ng/ml 
PooF 10ng/ml 
TGF-J31 2ng/ml 
IFN-o: 20U/ml 
IFN-J3 20U/ml 
Somatostatin 1fLM 
Bradykinin 10fLM 
CGRP 1fLM 
Glucagon 1 fLg/ml 
SubP 1fLM 
VIP 1fLM 
Met-enkephalin 1fLM 
Histamine 100 fLM 
fection ofCNTF promoter/CAT reporter gene constructs 
into astrocyte cells by several transfection methods. We 
assume that this is because only a subset (~10%) of 
astrocytes in culture express CNTF protein (Stockli et aI., 
1991). Since the transfection efficiency that we achieved 
in transfection experiments was about 10%, transfected 
CNTF -expressing cells would represent only ~ 1 % of all 
cells. It appears that the CNTF promoter may be weak, 
but the mRNA is very stable (half-life, ~6 h), thus ac-
counting for the moderate levels of mRNA that can be 
detected in astrocyte cultures and sciatic nerve. 
Since elevated cAMP levels can down-regulate CNTF 
mRNA expression, it might be supposed that this down-
regulation is mediated through phosphorylation by pro-
tein kinase A of the DNA binding protein CREB (cyclic 
AMP response element binding protein) which acts at 
the CRE (cyclic AMP response element) consensus se-
quence (for reviews see Brindle and Montminy, 1992; 
Karin et aI., 1989; Montminy et aI., 1990) to turn off 
CNTF gene transcription. However, we found no evi-
dence of a consensus CRE sequence within 2 kb up-
stream or 1 kb downstream of the CNTF transcrip-
tional start-site. A consensus sequence for the binding 
Effect on Schwann 
Time astrocytes cell 
.. --.~----- ------.- .. 
72h 3-fold t No effect 
24 h ..j.. No effect 
24 h No effect 
24h ,j. No effect 
24h ,j. 
24 h ..j.. No effect 
24h ,j. 
24 h ,j. 
24h ,j. 
24h ..j.. 
24h ..j.. 
5-48h No effect 
24h No effect 
24h No effect 
24h No effect 
3-24h No effect 
3-24h No effect 
3-24h No effect 
5-24h No effect No effect 
5h No effect 
5-24h No effect 
24 h No effect 
24h No effect 
5-48h No effect 
24h No effect 
4h No effect 
24 h No effect 
24h No effect 
24h No effect No effect 
24 h No effect No effect 
24 h No effect 
24h No effect 
3-24h No effect 
24h No effect 
24h No effect 
24h No effect 
3-24 h No effect 
24 h No effect 
24 h No effect 
24h No effect 
of the transcription-regulatory complex AP-l is found 
at position -72 in the human and rat genes. Whether 
this element is involved in regulation ofthe CNTF gene 
is as yet unclear. One possibility is that the transcrip-
tion factor CREB or the related molecule CREM down-
regulate CNTF transcription through the AP-l site, since 
it has been shown recently that both CREB and CREM 
can compete in vitro with members of the Jun DNA 
binding protein family for binding to the AP-l site and 
also that in vivo CREB and CREM can negatively regu-
late AP-l site dependant Jun-mediated transcription 
activation of a reporter gene construct (Masquilier and 
Sassone-Corsi,1992). 
The regulation of expression of CNTF mRNA in cul-
tures of rat astrocytes and Schwann cells was investi-
gated since these cell-types have already been demon-
strated to produce CNTF protein: astrocytes in culture 
(Lillien et aI., 1988; Stockli et aI., 1991) and in vivo 
(Stockli et aI., 1991) and Schwann cells in culture (Meyer 
et aI., 1992) and in vivo (Stockli et aI., 1991). CNTF 
mRNA has been demonstrated in cultures of rat astro-
cyte cells (Rudge et aI., 1992; Stockli et aI., 1989). Pri-
mary Schwann cells and astrocytes were isolated from 
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Fig. 4. Northern blot analysis of CNTF mRNA levels in 3-week-old astrocyte-enriched cultures from 
cells isolated from different brain regions, either untreated or treated for 24 h with forskolin (FK, 10 J.lM). 
I_I I_I I_I I_I I_I I_' I_I I_I 
HT ActD 
+FK 
3h 
Act D Act D 
+FK +FK 
6 h 20 h 
HT ActO Act D Act D 
3 h 6 h 20 h 
Fig. 5. Measurement ofCNTF mRNA half-life in 3-week-old astrocyte-enriched cultures from new-born 
rat brain. NT, untreated cells; Act D, actinomycin D (10 J.lg/m\); FK, forskolin (10 fLM). 
new-born rat sciatic nerves and brain (where the levels 
of CNTF mRNA in vivo at this developmental stage are 
negligible) and grown in culture for 2-4 weeks. 
Cultured Schwann cells, in contrast to the in vivo 
situation, expressed very low levels of CNTF mRNA 
and expression could not be increased by a variety of 
factors and growth conditions. We assume that the cells 
in culture do not follow their normal developmental 
programme which would be to begin to produce CNTF 
at about postnatal day four (Stockli et aI., 1991), or that 
specific in vivo requirements for CNTF expression are 
lacking when Schwann cells are grown in culture. Sendt-
ner et al. (1992a), Friedman et al. (1992), and Seniuk 
et al. (1992) have shown that CNTF mRNA is also down-
regulated in distal segments of the lesioned sciatic nerve, 
thus offering a plausible explanation for the lack of 
expression of CNTF mRNA in cultured Schwann cells, 
i.e., CNTF mRNA expression is correlated with intact 
nerve structure. 
In contrast to the situation in Schwann cells, cul-
• 
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tured brain astrocytes express moderate levels ofCNTF 
mRNA, although the levels in vivo in brain are rela-
tively low, apart from the olfactory bulb and optic nerve 
(SWckli et aI., 1991). 
CNTF mRNA can be down-regulated in astrocytes by 
forskolin, isoproterenol, norepinephrine, cAMP analogues, 
and by four members of the fibroblast growth factor 
(FGF) family. The physiological significance of these 
effects is unknown. Forskolin, norepinephrine, and iso-
proterenol are known to increase intracellular cyclic 
AMP levels: forskolin by activation of adenylate cyclase 
(Seamon et aI., 1981), isoproterenol, and norepineph-
rine through l3-adrenergic receptor activation (Atkin-
son and Minneman, 1991; Narumi et aI., 1978). That 
the forskolin analogue dideoxyforskolin, which lacks 
the adenylate cyclase activation activity of forskolin 
(Laurenza et aI., 1989), failed to lower CNTF mRNA 
levels is further evidence of a role for the cAMP second 
messenger pathway in the regulation of steady-state 
CNTF mRNA levels. The morphological changes induced 
by elevated intracellular cAMP levels in astrocytes, i.e., 
from polygonal to process-bearing cells, have been sug-
gested to represent a more differentiated state (Kemp-
ski et aI., 1987; Le Prince et aI., 1991; Pollenz and 
McCarthy, 1986). This would fit with the down-regula-
tion of CNTF mRNA by forskolin since in vivo CNTF 
mRNA levels are quite low in most brain regions (Stbckli 
et aI., 1991). bFGF causes similar morphological changes 
in cultured astrocytes (Perraud et aI., 1990 and refer-
ences therein). However, there does not seem to be a 
direct correlation between intracellular cAMP levels, 
morphological transformation, and CNTF mRNA levels 
since some factors that elevate cAMP levels in astro-
cytes MP (van Calker et aI., 1980), histamine (Agullo 
et aI., 1990), and calcitonin gene-related protein (Lazar 
et aI., 1991)] or cause morphological transformation [cal-
citonin gene-related protein (Lazar et aI., 1991), cal-
cium ionophores (Fawthrop and Evans, 1987), and PDGF 
(Besnard et al., 1987)] fail to down-regulate CNTF mRNA. 
bFGF also induces astrocyte proliferation in vitro (Pett-
man et aI., 1985) and is thought to be involved in re-
sponses of astrocytes to brain injury (Baird and Wal-
icke, 1989). Astrocytes in culture contain bFGF (Hatten 
et aI., 1988; Woodward et aI., 1992) but it appears not to 
be released and thus, as shown here, only exogenously 
applied bFGF can down-regulate CNTF mRNA. Whether 
bFGF regulates CNTF mRNA levels in vivo is unknown, 
but bFGF mRNA and protein levels are increased at the 
site of rat brain lesion (Finkelstein et aI., 1988; Frautchy 
et aI., 1991; Logan, 1990; Logan et aI., 1992). Paradoxi-
cally, in view of the down-regulation of CNTF mRNA 
levels by bFGF in astrocyte cultures as shown here, 
CNTF mRNA levels are also increased at the site of 
brain lesion in cells which appear to be undergoing 
reactive gliosis (Jp et aI., 1993). 
The down-regulation of CNTF mRNA levels in astro-
cytes by bFGF is in contrast to the up-regulation of 
NGF mRNA levels by bFGF in the same cells (Spranger 
et al., 1990). Furthermore, several treatments which 
increase NGF mRNA levels in astrocytes, e.g., IL-1, 
TGF-a, EGF (Spranger et aI., 1990), TGF-131 (Lindholm 
et al., 1992), and phorbol ester (Zafra et aI., 1992) had 
no effect on CNTF mRNA, which in addition to the 
differences in mRNA half-lives of CNTF (~6 h, this 
paper) and NGF (~90 min, Lindholm et aI., 1988) and 
absence of secretion signal peptide in CNTF (SWckli 
et aI., 1989), adds further evidence to support the idea 
that there are fundamental differences in the physio-
logical roles of these molecules. 
Of the factors investigated, only IFN --y elevated CNTF 
mRNA levels in astrocyte cultures. Indeed, in earlier 
experiments with human mixed spinal cord cultures, 
IFN--y stimulated production of a cholinergic inducing 
activity from nonneuronal cells (Erkman et aI., 1988). 
CNTF is an obvious candidate for such a factor. The 
cellular sources of IFN--y are T lymphocytes and natu-
ral killer cells (Bancroft et aI., 1987). IFN--y is not nor-
mally found in the CNS but astrocytes (Wong et aI., 
1984), Schwann cells (Samuel et aI., 1987), and oligo-
dendrocytes (Bergsteinsdottir et aI., 1992) in culture 
can be induced to express MHC class 11 antigens by 
IFN--y treatment and adult human astrocytes are in-
duced in vitro by IFN--y to proliferate (Yong et aI., 1991). 
Furthermore injection ofIFN--y into adult mouse brain 
promotes reactive gliosis at the injection site (Yong et aI., 
1991). It is hypothesised that T cell-derived IFN--y may 
play a role in some pathological situations where there 
is access of cells of the immune system to the CNS (for 
review see Olsson, 1992; Wekerle et aI., 1986). Eleva-
tion ofCNTF expression by IFN--y in astrocytes may be 
part of this response. 
Further experiments using transgenic mouse models 
are in progress to elucidate the mechanism of regula-
tion of CNTF expression in vivo. 
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